QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 4, 2006, 26(1):290-299; doi:10.1523/JNEUROSCI.3353-05.2006

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Breier, J. M. Articles by Yamamoto, B. K. Search for Related Content PubMed PubMed Citation Articles by Breier, J. M. Articles by Yamamoto, B. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 3,4-METHYLENEDIOXYMETHAMPHETAMINE L-TYROSINE Medline Plus Health Information Club Drugs

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
L-Tyrosine Contributes to (+)-3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletions

Joseph M. Breier, Michael G. Bankson, and Bryan K. Yamamoto

Laboratory of Neurochemistry, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118

The specific mechanisms underlying (+)-3,4-methylenedioxymethamphetamine (MDMA)-induced damage to 5-HT terminals are unknown. Despite the hypothesized role for dopamine (DA) and DA-derived free radicals in mediating this damage, it remains unclear why MDMA produces long-term depletions of 5-HT in brain regions that are sparsely innervated by DA neurons. We hypothesized that the precursor to DA biosynthesis, tyrosine, mediates MDMA-induced 5-HT depletions. Extracellular tyrosine concentrations increased fivefold in striatum and 2.5-fold in hippocampus during the administration of neurotoxic doses of MDMA. In vitro results show that L-tyrosine can be hydroxylated nonenzymatically to the DA precursor L-3,4-dihydroxyphenylalanine (DOPA) under pro-oxidant conditions. The local infusion of L-tyrosine into the striatum or hippocampus during MDMA administration potentiated the acute increase in extracellular DA and the long-term depletion of 5-HT after MDMA. Coinfusion of the aromatic amino acid decarboxylase (AADC) inhibitor m-hydroxybenzylhydrazine attenuated these effects in hippocampus and decreased basal extracellular DA in the striatum. In contrast, the reverse dialysis of the tyrosine hydroxylase inhibitor -methyl-p-tyrosine into the hippocampus did not affect MDMA-induced increases in extracellular DA or the long-term depletion in 5-HT. These results show that MDMA increases the concentration of tyrosine in the brain to cause a long-term depletion of 5-HT via the nonenzymatic, tyrosine hydroxylase-independent, hydroxylation of tyrosine to DOPA and subsequently to DA via AADC. Overall, the findings suggest that MDMA depletes 5-HT by increasing tyrosine and its eventual conversion to DA within 5-HT terminals.

Key words: dopamine; tyrosine; MDMA; striatum; hippocampus; serotonin

---

Received Aug 10, 2005; revised November 9, 2005; accepted November 10, 2005.

This article has been cited by other articles:

				K. S. Rau, E. Birdsall, T. J. Volz, J. A. Riordan, A. J. Baucum II, B. P. Adair, R. Bitter, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein Methamphetamine Administration Reduces Hippocampal Vesicular Monoamine Transporter-2 Uptake J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 676 - 682. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help